Application of Nanotechnology in Cancer Treatment and Biological Fields

Dear Colleagues,

Cancer ranks as a leading cause of death and one of the main barriers to increasing life expectancy around the world. The International Agency for Research on Cancer (IARC) estimated that 19.3 million new cases of cancer and almost 10.0 million deaths from cancer occurred in 2020. With the deepening understanding of cancer and the rapid development of interdisciplinarity in recent decades, nanomedicines and nanotechnologies have shown great application prospects in cancer therapies. Compared with traditional small molecule drugs, nanomedicines can focus on disease more efficiently and be specifically taken up by target cells, exhibiting many unique advantages, including satisfactory local drug concentrations in lesions and reduced systemic adverse effects. Herein, this topic will highlight the recently developed nanotechnologies and nanomedicines for enhancing cancer therapies, together with discussions about their applications in other disease-related biology fields. The present Special Issue of Nanomaterials aims to publish original research articles and reviews that cover current challenges in the efficient use of nanoparticles in the cancer treatment and biological fields. Original research papers, communications, and review articles are welcome.

Prof. Dr. Qian Chen
Dr. Huapan Fang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanomedicine
• nanotechnology
• cancer therapy
• biological field